National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Sofosbuvir (Solvaldi®) is indicated in combination with other medicinal products for the treatment of Chronic Hepatitis C in adults.

Rapid Review

Commenced Completed Outcome
12/02/2014 10/03/2014 Full Pharmacoeconomic Evaluation Recommended

Pharmacoeconomic Evaluation

Commenced Completed Outcome
03/06/2014  24/10/2014  Reimbursement Recommended for certain subgroups

Summary